Increased serum levels of MIC1/GDF15 correlated with bone erosion in spondyloarthritis: A pilot study

11Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

Abstract

Introduction: To assess the association between growth differentiation factor-15 (GDF15) and radiographic features including bone marrow edema and bone erosion in Spondyloarthritis (SpA). Methods: Patients with SpA (n = 120) receiving treatment in the Guangdong General Hospital, China, between August 2012 and December 2016 were retrospectively included. Serum of patients and healthy controls (n = 30) were collected and GDF15 levels were measured using ELISA. Inflammation was assessed by C-reactive protein (CRP), and magnetic resonance imaging (MRI) of the sacroiliac joint using Spondyloarthritis Research Consortium of Canada score and a method of dichotomy to assess fat metaplasia, bone erosion, and ankylosis. Radiographs of the pelvis were scored using the modified New York (mNY) score. Results: Serum GDF15 levels were higher in SpA patients compared to controls (503.52 ± 222.92 vs. 190.86 ± 104.18 pg/mL, P < .0001). Moreover, GDF15 levels were related to CRP levels (r = 0.5658, P

Cite

CITATION STYLE

APA

Song, Y., Cui, Y., Zhang, X., Lin, H., Zhang, G., Zeng, H., & Zeng, Y. (2018). Increased serum levels of MIC1/GDF15 correlated with bone erosion in spondyloarthritis: A pilot study. Medicine (United States), 97(51). https://doi.org/10.1097/MD.0000000000013733

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free